Immunization with Attenuated Salmonella typhimurium Producing Catalase in Protection against Gastric Helicobacter pylori Infection in Mice

Helicobacter

Volumn 8, Issue 6, 2003, Pages 613-625

  Chen, Minhu ^a   Chen, Jie ^a   Liao, Wenjun ^a   Zhu, Senlin ^a   Yu, Jun ^b   Leung, Wai K ^b   Hu, Pinjin ^a   Sung, Joseph J Y ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Catalase; Helicobacter pylori; Salmonella typhimurium; Vaccine

Indexed keywords

CATALASE; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIVE VACCINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL GENE; BACTERIAL IMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; STOMACH DISEASE; STOMACH MUCOSA; STOMACH PROTECTION; TH1 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CATALASE; CYTOKINES; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNIZATION; MICE; MICE, INBRED C57BL; PLASMIDS; RNA, MESSENGER; SALMONELLA TYPHIMURIUM; SONICATION;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; SALMONELLA TYPHIMURIUM;

EID: 0346093636     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2003.00182.x     Document Type: Article

References (48)

1. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-41.
2. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
3. World Health Organization. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. France: International Agency for Research on Cancer (IARC), 1994;177-240.
4. Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol 1993;196:34-7.
5. Goddard AF, Logan RP. Antimicrobial resistance and Helicobacter pylori. J Antimicrob Chemother 1996;37:639-43.
6. Lahaie RG, Gaudreau C. Helicobacter pylori antibiotic resistance: trends over time. Can J Gastroenterol 2000;14:895-9.
7. Radcliff FJ, Hazell SL, Kolesnikow T, Doidge C, Lee A. Catalase, a novel antigen for Helicobacter pylori vaccination. Infect Immun 1997;65:4668-74.
8. Gomez-Duarte OG, Bumann D, Meyer TF. The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases. Vaccine 1999;17:1667-73.
9. Bullas LR, Ryu JI. Salmonella typhimurium LT2 strains which are r- m+ for all three chromosomally located systems of DNA restriction and modification. J Bacteriol 1983;15:471-4.
10. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981;291:238-9.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, A Laboratory Manual (2nd edn). New York: Cold Spring HarborLaboratory Press, 1989;1.82-1.84.
12. Kleanthous H, Lee CK, Monath TP. Vaccine development against infection with Helicobacter pylori. Br Med Bull 1998;54:229-41.
13. Sutton P, Lee A. Helicobacter pylori vaccines - the current status. Aliment Pharmacol Ther 2000;14:1107-18.
14. Sutton P. Progress in vaccination against Helicobacter pylori. Vaccine 2001;19:2286-90.
15. Dubois A, Lee CK, Fiala N, Kleanthous H, Mehlman PT, Monath T. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun 1998;66:4340-6.
16. Chen M, Lee A, Hazell S. Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model. Lancet 1992;339:1120-1.
17. Galen JE, Gomez-Duarte OG, Losonsky GA, et al. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 1997;15:700-8.
18. Harokopakis E, Hajishengallis G, Greenway TE, Russell MW, Michalek SM. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. Infect Immun 1997;65:1445-54.
19. VanCott JL, Staats HF, Pascual DW, et al. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol 1996;156:1504-14.
20. Chatfield SN, Strugnell RA, Dougan G. Live Salmonella as vaccines and carriers of foreign antigenic determinants. Vaccine 1989;7:495-8.
21. Corthesy-Theulaz IE, Hopkins S, Bachmann D, et al. Mice are protected from Helicobacterpylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun 1998;66:581-6.
22. Tacket CO, Sztein MB, Losonsky GA, et al. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun 1997;65:452-6.
23. Angelakopoulos H, Hohmann EL. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 2000; 68:2135-41.
24. Hopkins S, Kraehenbuhl JP, Schodel F, et al. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 1995;63:3279-86.
25. Nardelli-Haefliger D, Kraehenbuhl JP, Curtiss R, et al. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect Immun 1996;64:5219-24.
26. Hazell SL, Evans DJ Jr, Graham DY. Helicobacter pylori catalase. J Gen Microbiol 1991;137:57-61.
27. Jiang B, Jordana M, Xing Z, et al. Replication-defective adenovirus infection reduces Helicobacter felis colonization in the mouse in a gamma-interferon and interleukin-12-dependent manner. Infect Immun 1999;67:4539-44.
28. Catmull J, Wilson ME, Kirchhoff LV, Metwali A, Donelson JE. Induction of specific cell-mediated immunity in mice by oral immunization with Salmonella expressing Onchocerca volvulus glutathione S-transferase. Vaccine 1999;17:31-9.
29. Goto T, Nishizono A, Fujioka T, Ikewaki J, Mifune K, Nasu M. A Local secretary immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice. Infect Immun 1999;67:2531-99.
30. Gomez-Duarte OG, Lucas B, Yan ZX, Panthel K, Haas R, Meyer TF. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 1998;16:460-71.
31. Ferrero RL, Thiberge JM, Kansan I. Immunization with Helicobacter pylori heat shock protein A (HspA) and urease subunit B (ure B) affords total protection against H. felis infection in mice. Gut 1995;37:A203.
32. Marchetti M, Rossi M, Giannelli V, et al. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 1998;16:33-7.
33. Miroslav J, Novac LE, Smythies SA. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit TH1 associated immune response. Vaccine 1999;17:2384-91.
34. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386-97.
35. Michetti P, Kreiss C, Kotloff KL, et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 1999;116:804-12.
36. DiPetrillo MD, Tibbetts T, Kleanthous H, Killeen KP, Hohmann EL. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacterpylori urease in adult volunteers. Vaccine 1999;18:449-59.
37. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter 2001;6:116-24.
38. Ermak TH, Ding R, Ekstein B, et al. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology 1997;113:1118-28.
39. Kotloff KL, Sztein MB, Wasserman SS, Losonsky GA, DiLorenzo SC, Walker RI. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 2001;69:3581-90.
40. KoeslingJ, Lucas B, Develioglou L, Aebischer T, Meyer TF. Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy. Vaccine 2001; 20:413-20.
41. Comoy EE, Capron A, Thyphronitis G. In vivo induction of type 1 and 2 immune responses against protein antigens. Int Immunol 1997;9:523-31.
42. Sommer F, Faller G, Konturek P, et al. Antrumand corpus mucosa-infiltrating CD4 (+) lymphocytes in Helicobacterpylori gastritis display a Thl phenotype. Infect Immun 1998;66:5543-6.
43. D'Elios MM, Manghetti M, De Carli M, et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997;158:962-7.
44. Bumann D, Metzger WG, Mansouri E, et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 2001;20:845-52.
45. Eaton KA, Ringler SR, Danon SJ. Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice. Infect Immun 1999;67:4594-602.
46. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ. Murine CD4+ T-cell response to Helicobacter infection. Th1 cells enhance gastritis and Th2 cells reduce bacterial load. Gastroenterology 1997;113:1848-57.
47. Sutton P, Danon SJ, Walker M, et al. Post-immunization gastritis and Helicobacter infection in the mouse: a long term study. Gut 2001;49:467-73.
48. Okahashi N, Yamamoto M, Vancott JL, Chatfield SN, et al. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect Immun 1996;64:1516-25.